SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review

Journal of Infection and Public Health - Tập 15 - Trang 515-525 - 2022
Jonaid Ahmad Malik1,2, Mir Aroosa3, Sakeel Ahmed4, Mrunal Shinde5, Saleh Alghamdi6, Khaled Almansour7, Turki Al Hagbani7, Muteb Sultan Alanazi8, Sirajudheen Anwar9
1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, India
2Department of Biomedical Engineering, Indian Institute of Technology Ropar, Rupnagar Punjab, India
3Department of Pharmacology, Jamia Hamdard, New Delhi, India
4Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, India
5Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, India
6Department of Clinical Pharmacy, Faculty of Clinical Pharmacy, Al Baha University, Al Baha, Saudi Arabia
7Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail, Saudi Arabia
8Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia
9Department of Pharmacology, College of Pharmacy, University of Hail, Hail, Saudi Arabia

Tài liệu tham khảo

Farooqi, 2021, An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies, J Infect Public Health, 14, 1299, 10.1016/j.jiph.2021.08.014 Malik, 2020, COVID-19: An overview of current scenario, CELLMED, 10, 21.1 Malik, 2021, Targets and strategies for vaccine development against SARS-CoV-2, Biomed Pharmacother, 137, 10.1016/j.biopha.2021.111254 Malik, 2022, The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges, J Infect Public Health, 15, 228, 10.1016/j.jiph.2021.12.014 Albanghali, 2022, Clinical Characteristics and Treatment Outcomes of Mild to Moderate COVID-19 Patients at Tertiary Care Hospital, Al Baha, Saudi Arabia: A Single Centre Study, J Infect Public Health, 15, 331, 10.1016/j.jiph.2022.02.001 Ahmad Malik, 2022, The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It, Saudi J Biol Sci, 29, 3586, 10.1016/j.sjbs.2022.02.006 V.C.C. Cheng , I.F.N. Hung , B.S.F. Tang , C.M. Chu , M.M.L. Wong , K.H. Chan , et al. , Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome, (2004). To, 2020, Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during Infection by SARS-CoV-2: an observational cohort study, Lancet Infect Dis, 20, 565, 10.1016/S1473-3099(20)30196-1 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Oxley, 2020, Large-vessel stroke as a presenting feature of covid-19 in the young, N Engl J Med, 382, 10.1056/NEJMc2009787 Giamarellos-Bourboulis, 2020, Complex immune dysregulation in COVID-19 patients with severe respiratory failure, Cell Host Microbe, 27, 992, 10.1016/j.chom.2020.04.009 Chen, 2020, Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically Ill patients with coronavirus disease 2019, Clin Infect Dis, 71, 1937, 10.1093/cid/ciaa449 Fajnzylber, 2020, SARS-CoV-2 viral load is associated with increased disease severity and mortality, Nat Commun, 11, 1, 10.1038/s41467-020-19057-5 Gallo Marin, 2021, Predictors of COVID-19 severity: a literature review, Rev Med Virol, 31, 1, 10.1002/rmv.2146 Zhang, 2020, D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19, J Thromb Haemost, 18, 1324, 10.1111/jth.14859 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA - J Am Med Assoc, 323, 1061, 10.1001/jama.2020.1585 A. Ma, J. Cheng, J. Yang, M. Dong, X. Liao, Y. Kang, NLR neutrophil linfocito ratio Covid ARDS grave, (2020) 24–27. Piano, 2020, Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19, Liver Int, 40, 2394, 10.1111/liv.14565 Hui, 2020, Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures, Lancet Respir Med, 8, 687, 10.1016/S2213-2600(20)30193-4 Lauer, 2020, The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application, Ann Intern Med, 172, 577, 10.7326/M20-0504 Ripabelli, 2021, A coronavirus outbreak linked to a funeral among a Romani community in central Italy, Front Med, 8, 1, 10.3389/fmed.2021.617264 Cevik, 2020, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission dynamics should inform policy, Clin Infect Dis Buitrago-Garcia, 2020, Occurrence and transmission potential of asymptomatic and pre-symptomatic SARSCoV-2 infections: a living systematic review and meta-analysis, PLoS Med, 17, 10.1371/journal.pmed.1003346 Yu, 2004, Evidence of airborne transmission of the severe acute respiratory syndrome virus, N Engl J Med, 350, 1731, 10.1056/NEJMoa032867 van Doremalen, 2020, Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, N Engl J Med, 382, 1564, 10.1056/NEJMc2004973 Cevik, 2021, SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis, Lancet Microbe, 2, e13, 10.1016/S2666-5247(20)30172-5 Kang, 2020, Probable evidence of fecal aerosol transmission of SARS-CoV-2 in a high-rise building, Ann Intern Med, 173, 974, 10.7326/M20-0928 Hodgson, 2021, What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2, Lancet Infect Dis, 21, e26, 10.1016/S1473-3099(20)30773-8 Van Tilbeurgh, 2021, Predictive markers of immunogenicity and efficacy for human vaccines, Vaccines, 9, 1, 10.3390/vaccines9060579 Ura, 2021, New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates, vaccine, 39, 197, 10.1016/j.vaccine.2020.11.054 Mehrotra, 2021, Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials, Ann Intern Med, 174, 221, 10.7326/M20-6169 Lin, 2020, Evaluating the efficacy of coronavirus disease 2019 vaccines, Clin Infect Dis, 7420, 1 Docherty, 2020, Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study, Br Med J, 369, 1 Oran, 2020, Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review, Ann Intern Med, 173, 362, 10.7326/M20-3012 Long, 2020, Antibody responses to SARS-CoV-2 in patients with COVID-19, Nat Med, 26, 845, 10.1038/s41591-020-0897-1 Thanh Le, 2020, The COVID-19 vaccine development landscape, Nat Rev Drug Discov, 19, 305, 10.1038/d41573-020-00073-5 Younes, 2020, Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2, Viruses, 12, 1, 10.3390/v12060582 Lipsitch, 2020, Antibody testing will enhance the power and accuracy of COVID-19-prevention trials, Nat Med, 26, 818, 10.1038/s41591-020-0887-3 Beigel, 2020, Remdesivir for the treatment of covid-19 — final report, N Engl J Med, 383, 1813, 10.1056/NEJMoa2007764 Younes, 2020, Challenges in laboratory diagnosis of the novel, Viruses, 12, 582, 10.3390/v12060582 Zhu, 2020, Clinical characteristics of 3062 COVID-19 patients: a meta-analysis, J Med Virol, 92, 1902, 10.1002/jmv.25884 Busani, 2020, Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 Infection: a structured summary of a study protocol for a randomised cont, Trials, 21, 1, 10.1186/s13063-020-04645-z Sholzberg, 2021, Coagulopathy of hospitalised COVID-19: a pragmatic randomised controlled trial of therapeutic anticoagulation versus standard care as a rapid response to the COVID-19 pandemic (RAPID COVID COAG – RAPID Trial): a structured summary of a study protocol for, Trials, 22, 1, 10.1186/s13063-021-05076-0 Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China, Jama, 323, 1239, 10.1001/jama.2020.2648 Stokes, 2020, Coronavirus disease 2019 case surveillance — United States, January 22–May 30, 2020, Morb Mortal Wkly Rep, 69, 759, 10.15585/mmwr.mm6924e2 Clark, 2020, Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study, Lancet Glob Health, 8, e1003, 10.1016/S2214-109X(20)30264-3 Ripabelli, 2021, Active surveillance of adverse events in healthcare workers recipients after vaccination with COVID-19 BNT162b2 vaccine (Pfizer-BioNTech, Comirnaty): a cross-sectional study, J Community Health SCT Partnership, 2015, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial, Lancet, 386, 31, 10.1016/S0140-6736(15)60721-8 McCaw, 2020, Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19, Contemp Clin Trials, 97, 10.1016/j.cct.2020.106145 Wang, 2020, Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 395, 1569, 10.1016/S0140-6736(20)31022-9 Khan, 2020, Transmission of SARS-CoV-2, required developments in research and associated public health concerns, Front Med, 7, 1, 10.3389/fmed.2020.00310 Yesudhas, 2021, COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics, infection, 49, 199, 10.1007/s15010-020-01516-2 Zheng, 2020, Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: Retrospective cohort study, Br Med J, 369, 1 To, 2020, Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during Infection by SARS-CoV-2: an observational cohort study, Lancet Infect Dis, 20, 565, 10.1016/S1473-3099(20)30196-1 Wölfel, 2020, Virological assessment of hospitalized patients with COVID-2019, Nature, 581, 465, 10.1038/s41586-020-2196-x Kim, 2020, The architecture of SARS-CoV-2 transcriptome, Cell, 181, 914, 10.1016/j.cell.2020.04.011 Alexandersen, 2020, SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication, Nat Commun, 11, 10.1038/s41467-020-19883-7 Yu, 2020, D.N.A. vaccine protection against SARS-CoV-2 in rhesus macaques, Science, 369, 806, 10.1126/science.abc6284 Addetia, 2020, Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate, J Clin Microbiol, 58, 10.1128/JCM.02107-20 Vabret, 2020, Immunology of COVID-19: current state of the science, Immunity, 52, 910, 10.1016/j.immuni.2020.05.002 Jin, 2021, Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need, Signal Transduct Target Ther, 6, 2, 10.1038/s41392-021-00481-y Chandrashekar, 2020, SARS-CoV-2 Infection protects against rechallenge in rhesus macaques, Science, 369, 812, 10.1126/science.abc4776 Eyal, 2021, Human challenge studies to accelerate coronavirus vaccine licensure, J Infect Dis, 221, 1752, 10.1093/infdis/jiaa152 Marietta, 2020, Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a struc, Trials, 21, 1, 10.1186/s13063-020-04475-z Tornero, 2020, A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): a structured summary of a study protocol for a randomised contr, Trials, 21, 20, 10.1186/s13063-020-04486-w Dodd, 2020, Endpoints for randomized controlled clinical trials for COVID-19 treatments, Clin Trials, 17, 472, 10.1177/1740774520939938 Arons, 2020, Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility, N Engl J Med, 382, 2081, 10.1056/NEJMoa2008457 W. Tan , Y. Lu , J. Zhang , J. Wang , Y. Dan , Z. Tan, et al. , Viral kinetics and antibody responses in patients with COVID-19, (2020). 〈https://doi.org/10.1101/2020.03.24.20042382〉. Moynihan, 2004, Psychosocial factors and the response to influenza vaccination in older adults, Psychosom Med, 66, 950, 10.1097/01.psy.0000140001.49208.2d Glaser, 2000, Chronic stress modulates the immune response to a pneumococcal pneumoaia vaccine, Psychosom Med, 62, 804, 10.1097/00006842-200011000-00010 Li, 2007, Effects of chronic stress and interleukin-10 gene polymorphisms on antibody response to tetanus vaccine in family caregivers of patients with Alzheimer’s disease, Psychosom Med, 69, 551, 10.1097/PSY.0b013e3180cc2c61 Dhabhar, 2014, Effects of stress on immune function: the good, the bad, and the beautiful, Immunol Res, 58, 193, 10.1007/s12026-014-8517-0 Christ, 2019, Western diet and the immune system: an inflammatory connection, Immunity, 51, 794, 10.1016/j.immuni.2019.09.020 David, 2014, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820 Lee, 2020, Incremental validity of coronaphobia: coronavirus anxiety explains depression, generalized anxiety, and death anxiety, J Anxiety Disord, 74, 10.1016/j.janxdis.2020.102268 Chang, 1994, Reduction in burden of illness: a new efficacy measure for prevention trials, Stat Med, 13, 1807, 10.1002/sim.4780131803 Fleming, 2012, Biomarkers and surrogate endpoints in clinical trials, Stat Med, 31, 2973, 10.1002/sim.5403 Zhu, 2020, Clinical characteristics of 3062 COVID-19 patients: a meta-analysis, J Med Virol, 92, 1902, 10.1002/jmv.25884 Madison, 2021, Psychological and behavioral predictors of vaccine efficacy: considerations for COVID-19, Perspect Psychol Sci, 16, 191, 10.1177/1745691621989243 Bartlett, 2009, PR receptors, vaccine immunology overview, Dermatol Ther, 22, 1, 10.1111/j.1529-8019.2009.01223.x Dan, 2021, Immunological memory to SARS-CoV-2 assessed for up to 8 months after Infection, Science, 371, 10.1126/science.abf4063 Poland, 2020, SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates, Lancet, 396, 1595, 10.1016/S0140-6736(20)32137-1 Bocchini, 2008, Recommended immunization schedules for children and adolescents - United States, 2008, Pediatrics, 121, 219, 10.1542/peds.2007-3280 Burns, 2003, Life events, perceived stress and antibody response to influenza vaccination in young, healthy adults, J Psychosom Res, 55, 569, 10.1016/S0022-3999(03)00073-4 Kwetkat, 2020, Comorbidities in the elderly and their possible influence on vaccine response, Interdiscip Top Gerontol Geriatr, 43, 73, 10.1159/000504491 Glaser, 2005, Stress-induced immune dysfunction: implications for health, Nat Rev Immunol, 5, 243, 10.1038/nri1571 Franceschi, 2000, Inflamm-aging. An evolutionary perspective on immunosenescence, Ann N Y Acad Sci, 908, 244, 10.1111/j.1749-6632.2000.tb06651.x Gallagher, 2008, Psychosocial factors are associated with the antibody response to both thymus-dependent and thymus-independent vaccines, Brain, Behav, Immun, 22, 456, 10.1016/j.bbi.2007.10.018 Segerstrom, 2008, Caregiving, repetitive thought, and immune response to vaccination in older adults, Brain Behav Immun, 22, 744, 10.1016/j.bbi.2007.11.004 Glaser, 1992, Stress-Induced Modulation of the Immune Response to Recombinant Hepatitis B Vaccine Ongoing studies in our laboratory and others have addressed the impact of both severe and commonplace stressful events on immune modulation ( 1-5). Data from studies with, Psychosom Med, 54, 22, 10.1097/00006842-199201000-00005 Kiecolt-Glaser, 1996, Chronic stress alters the immune response to influenza virus vaccine in older adults, Proc Natl Acad Sci USA, 93, 3043, 10.1073/pnas.93.7.3043 Brydon, 2009, Dispositional optimism and stress-induced changes in immunity and negative mood, Brain Behav Immun, 23, 810, 10.1016/j.bbi.2009.02.018 Kiecolt-Glaser, 2015, Inflammation: depression fans the flames and feasts on the heat, Am J Psychiatry, 172, 1075, 10.1176/appi.ajp.2015.15020152 Vukmanovic-Stejic, 2018, Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase–induced inflammation, J Allergy Clin Immunol, 142, 844, 10.1016/j.jaci.2017.10.032 Irwin, 2013, Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of anti-depressant medications, Clin Infect Dis, 56, 1085, 10.1093/cid/cis1208 Fitzpatrick, 2020, Living in the midst of fear: depressive symptomatology among US adults during the COVID-19 pandemic, Depress Anxiety, 37, 957, 10.1002/da.23080 Reiter, 2020, Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated?, Vaccine, 38, 6500, 10.1016/j.vaccine.2020.08.043 Pressman, 2005, Loneliness, social network size, and immune response to influenza vaccination in college freshmen, Health Psychol, 24, 297, 10.1037/0278-6133.24.3.297 Haberer, 2017, Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring, Aids, 31, 169, 10.1097/QAD.0000000000001310 Butler, 2020, The impact of nutrition on COVID-19 susceptibility and long-term consequences, Brain Behav Immun, 87, 53, 10.1016/j.bbi.2020.04.040 Harris, 2018, Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan, Gut Microbes, 9, 93, 10.1080/19490976.2017.1376162 Huda, 2014, Stool microbiota and vaccine responses of infants, Pediatrics, 134, 10.1542/peds.2013-3937 Lynn, 2017, The potential of the microbiota to influence vaccine responses, J Leukoc Biol, 103 Burns, 2002, Perceived stress and psychological well-being are associated with antibody status after meningitis C conjugate vaccination, Psychosom Med, 64, 963 Spiegel, 2002, Effect of sleep deprivation on response to immunization, JAMA, 288, 1471, 10.1001/jama.288.12.1469 Prather, 2012, Sleep and antibody response to hepatitis B vaccination, Sleep, 35, 1063 Wong, 2019, Hallmarks of improved immunological responses in the vaccination of more physically active elderly females, Exerc Immunol Rev, 25, 20 Clay, 2020, Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis?, The Lancet Public Health, 5, 10.1016/S2468-2667(20)30088-8 Lin, 2021, The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status, Sleep Med, 77, 348, 10.1016/j.sleep.2020.05.018 Hao, 2020, Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry, Brain Behav Immun, 87, 100, 10.1016/j.bbi.2020.04.069 Pellegrini, 2020, Changes in weight and nutritional habits in adults with obesity during the “lockdown” period caused by the COVID-19 virus emergency, Nutrients, 12, 1, 10.3390/nu12072016 Rundle, 2020, COVID-19-related school closings and risk of weight gain among children, Obesity, 28, 1008, 10.1002/oby.22813 Vedhara, 2019, Psychological interventions as vaccine adjuvants: a systematic review, Vaccine, 37, 3255, 10.1016/j.vaccine.2019.04.091 Pascoe, 2014, The effects of exercise on vaccination responses: a review of chronic and acute exercise interventions in humans, Brain Behav Immun, 39, 33, 10.1016/j.bbi.2013.10.003 Wouters-Wesseling, 2002, Effect of a complete nutritional supplement on antibody response to influenza vaccine in elderly people, J Gerontol Ser A Biol Sci Med Sci, 57, 10.1093/gerona/57.9.M563 Barnett, 2016, Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial, Am J Clin Nutr, 103, 942, 10.3945/ajcn.115.115188